laitimes

UBS suggested overweighting, and Hong Kong stocks welcomed three major positives

author:Red kangaroo and beckoning cat
UBS suggested overweighting, and Hong Kong stocks welcomed three major positives

Recently, the Hong Kong stock market has shown strong signs of recovery. It's not just the strong performance of the market itself, but also a series of important positive news that continues to drive the market higher. Among them, UBS's upgrade of Chinese mainland and Hong Kong stocks to overweight is undoubtedly one of the most talked about positive news.

Core indices such as the Hang Seng Index, Hang Seng Technology, and Hang Seng Pharma all rose sharply.

UBS suggested overweighting, and Hong Kong stocks welcomed three major positives

On Friday, the China Securities Regulatory Commission (CSRC) announced five measures for cooperation with Hong Kong, including the relaxation of ETF products, the inclusion of REITs, support for renminbi trading counters, the enhancement of mutual recognition of funds, and the smoothing of listing and financing channels. These measures will help strengthen the mutual access between Hong Kong stocks and the mainland capital markets, introduce new capital into Hong Kong's capital market, and further enhance market liquidity.

UBS upgraded Chinese mainland and Hong Kong equities to overweight. The report points out that among the constituent stocks of the MSCI China Index, the consumer and Internet sectors have a large weight, and with the recovery of the consumer market, the performance expectations of related companies are more optimistic.

At the same time, the recent volatility in the Asia-Pacific foreign exchange market has eased. The yen is gradually strengthening, the dollar index is starting to retreat, and the volatility in the external financial markets seems to have slowed somewhat.

For Hong Kong stocks, after experiencing the pullback in the previous period, it may usher in an opportunity to re-emerge. ChinaAMC Hang Seng Technology ETF Initiation Feeder (QDII) A (013402) and ChinaAMC Hang Seng Hong Kong-listed Biotech ETF (QDII) (159892) would be better investment targets.

UBS suggested overweighting, and Hong Kong stocks welcomed three major positives
UBS suggested overweighting, and Hong Kong stocks welcomed three major positives

ChinaAMC Hang Seng Technology ETF Initiation Linked (QDII) A (013402) has obvious investment value as a tool to invest in Hong Kong stock technology leaders.

The Hang Seng TECH Index brings together leading companies in the technology or innovation sector listed in Hong Kong, such as Alibaba, Tencent, JD.com, etc. These companies not only occupy a leading position in the Chinese market, but also become important players in the global connected technology industry. The Hang Seng TECH Index has demonstrated significant growth potential and investment value due to its high R&D investment, rapid revenue growth and strong market position.

At a time when the valuation of Hong Kong stocks is currently at a low level, it is only a fire.

This fire is the improvement of mobility.

As long as there is some "wind blowing", it is likely to usher in a large rebound with a retaliation.

#央媒: It is forbidden to hang bed curtains in the dormitory, which is suspected of laziness#

#失踪多日南充女教师已找到#

#多地高校禁止学生宿舍挂床帘#

$ChinaAMC Hang Seng Technology ETF Initiating Feeder (QDII)A(OTCFUND|013402)$

$贵州茅台(SH600519)$

$腾讯控股(Right|00700)$